TIMELESS is overexpressed in lung cancer and its expression correlates with poor patient survival

Cancer Science

Volumn 104, Issue 2, 2013, Pages 171-177

  Yoshida, Kenya ^a   Sato, Mitsuo ^a   Hase, Tetsunari ^a   Elshazley, Momen ^a   Yamashita, Ryo ^a   Usami, Noriyasu ^a   Taniguchi, Tetsuo ^a   Yokoi, Kohei ^a   Nakamura, Shigeo ^b   Kondo, Masashi ^a   Girard, Luc ^c   Minna, John D ^c   Hasegawa, Yoshinori ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TIMELESS;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUTATION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MICROARRAY; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DOXORUBICIN; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; SMALL CELL LUNG CARCINOMA;

EID: 84873726281     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12068     Document Type: Article

References (20)

1. Elshazley M, Sato M, Hase T et al. The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma. Int J Cancer 2012; 15: 2820-31.
2. Dunlap JC. Molecular bases for circadian clocks. Cell 1999; 96: 271-90.
3. Scully AL, Kay SA. Time flies for Drosophila. Cell 2000; 100: 297-300.
4. Zylka MJ, Shearman LP, Levine JD, Jin X, Weaver DR, Reppert SM. Molecular analysis of mammalian timeless. Neuron 1998; 21: 1115-22.
5. Barnes JW, Tischkau SA, Barnes JA et al. Requirement of mammalian Timeless for circadian rhythmicity. Science 2003; 302: 439-42.
6. Benna C, Scannapieco P, Piccin A et al. A second timeless gene in Drosophila shares greater sequence similarity with mammalian tim. Curr Biol 2000; 10: R512-3.
7. Gotter AL, Manganaro T, Weaver DR et al. A time-less function for mouse timeless. Nat Neurosci 2000; 3: 755-6.
8. Sjoblom T, Jones S, Wood LD et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006; 314: 268-74.
9. Yang X, Wood PA, Hrushesky WJ. Mammalian TIMELESS is required for ATM-dependent CHK2 activation and G2/M checkpoint control. J Biol Chem 2010; 285: 3030-34.
10. Fu A, Leaderer D, Zheng T, Hoffman AE, Stevens RG, Zhu Y. Genetic and epigenetic associations of circadian gene TIMELESS and breast cancer risk. Mol Carcinog 2011; 51: 923-9.
11. Sato M, Shames DS, Gazdar AF, Minna JD. A translational view of the molecular pathogenesis of lung cancer. J Thorac Oncol 2007; 2: 327-43.
12. Ramirez RD, Sheridan S, Girard L et al. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 2004; 64: 9027-34.
13. Sato M, Girard L, Sekine I et al. Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer. Oncogene 2003; 22: 7243-6.
14. Sato M, Vaughan MB, Girard L et al. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res 2006; 66: 2116-28.
15. Xiao J, Li C, Zhu NL, Borok Z, Minoo P. Timeless in lung morphogenesis. Dev Dyn 2003; 228: 82-94.
16. Sugimura H, Nichols FC, Yang P et al. Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg 2007; 83: 409-17; Discussion 17-8.
17. Schepeler T, Lamy P, Laurberg JR et al. A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response. Oncogene 2012; doi: 10.1038/onc.2012.381.
18. Clugston CK, McLaughlin K, Kenny MK, Brown R. Binding of human single-stranded DNA binding protein to DNA damaged by the anticancer drug cis-diamminedichloroplatinum (II). Cancer Res 1992; 52: 6375-9.
19. Gotter AL, Suppa C, Emanuel BS. Mammalian TIMELESS and Tipin are evolutionarily conserved replication fork-associated factors. J Mol Biol 2007; 366: 36-52.
20. Mitsudomi T, Steinberg SM, Nau MM et al. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 1992; 7: 171-80.